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The strategies by which intracellular pathogenic bacteria manipulate innate immunity to 
establish chronicity are poorly understood. Here we show that B. abortus outer membrane 
protein Omp25 specifically binds the immune cell receptor SLAMF1 in vitro. The Omp25-
dependent engagement of SLAMF1 by B. abortus limits NF-κB translocation in dendritic 
cells (DC) with no impact on Brucella intracellular trafficking and replication. This in turn 
decreases pro-inflammatory cytokine secretion and impairs DC activation. The Omp25-
SLAMF1 axis also dampens the immune response without affecting bacterial replication in 
vivo during the acute phase of Brucella infection in a mouse model. In contrast, at the chronic 
stage of infection, the Omp25/SLAMF1 engagement is essential for Brucella persistence. 
Interaction of a specific bacterial protein with an immune cell receptor expressed on the DC 
surface at the acute stage of infection is thus a powerful mechanism to support microbe 
settling in its replicative niche and progression to chronicity.  
  




A key issue for intracellular bacteria is to find a way to disseminate and survive to establish 
chronic infection. Bacteria have therefore developed efficient strategies to evade immune 
system recognition and elimination (Brodsky and Medzhitov, 2009; Sansonetti and Di Santo, 
2007). Targeting the signalling triggered by pattern recognition receptors in antigen 
presenting cells is one of them (Byndloss and Tsolis, 2016b). However little is known about 
other cell surface host-bacteria interacting factors that contribute to promoting chronicity and 
a firm demonstration of a direct link between such interaction and progress towards chronic 
infection is still under scrutiny.  
Brucella spp. are Gram-negative facultative intracellular coccobacilli, which are the causative 
agent of brucellosis, a worldwide re-emerging zoonosis affecting live stock (bovine for B. 
abortus, ovine and caprine for B. melitensis, swine for B. suis) and wild life with serious 
economic loss, as Brucella infected animals undergo spontaneous abortion and infertility 
(Corbel, 1997; Cutler et al., 2005; Moreno, 2014). Brucellosis can be transmitted to humans 
via contaminated food or infected aerosol particles. Acute human brucellosis is characterised 
by an undulant febrile illness, which if left untreated as often the case, leads to chronic 
inflammation (Dean et al., 2012; Pappas et al., 2005). Due to its high infectivity, Brucella has 
been classified as a potential warfare agent (Robinson-Dunn, 2002) and is manipulated in 
BSL3 only. Brucella spp. have the ability to enter, survive and replicate within non-
phagocytic or phagocytic cells, and as such evade host immune system defence mechanisms 
(Byndloss and Tsolis, 2016a; Gorvel and Moreno, 2002; Martirosyan et al., 2011; von Bargen 
This article is protected by copyright. All rights reserved.
  
et al., 2012). These properties may account for human brucellosis particularities (Skendros et 
al., 2011).  
Dendritic cells (DCs), which display a higher susceptibility than macrophages to Brucella 
infection (Billard et al., 2005),  are essential for the induction of innate and adaptive immune 
responses against this pathogen (Avila-Calderon et al., 2019; Papadopoulos and Gorvel, 
2015). DCs control bacterial growth through secretion of pro-inflammatory cytokines such as 
interleukin-12 (IL-12) or enzyme like NOS2 (Copin et al., 2007; Macedo et al., 2008). A 
number of bacterial effectors, including BtpA and BtpB proteins (Salcedo et al., 2013; 
Salcedo et al., 2008), and a non-canonical LPS (Conde-Alvarez et al., 2012; Zhao et al., 
2018), help Brucella survive in phagosomes, settle in their safe replication niche, the 
endoplasmic reticulum (ER), and/or modulate DC activation. The outer membrane protein 
Omp25, a major transmembrane protein, also regulates immune response against Brucella. In 
vitro, Brucella Omp25-defective mutants (∆omp25) induce human monocyte (mo)-DC and 
macrophage activation, which results in TNF-α and IL-12 secretion (Billard et al., 2007; 
Jubier-Maurin et al., 2001). In vivo, the role of Brucella Omp25 is controversial since B. 
abortus or B. melitensis ∆omp25 mutants are either attenuated (Edmonds et al., 2002) or as 
virulent as the wild-type parental strains (Manterola et al., 2007). Even though Omp25 has 
been considered as a potential vaccine (Byndloss and Tsolis, 2016a; Commander et al., 2010; 
Commander et al., 2007; Goel and Bhatnagar, 2012; Goel et al., 2013), further work is needed 
to clarify the role of this outer membrane protein in the regulation of host immune responses. 
A previous transcriptomics study led us identify SLAMF1 as a strongly upregulated gene in 
human monocyte-derived DCs (mo-DCs) stimulated with Brucella β1,2 cyclic glucan (CβG) 
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(Degos et al., 2015; Martirosyan et al., 2012). SLAMF1 is a cell surface receptor belonging to 
the signalling lymphocyte activation molecule family (SLAMF), itself a member of the 
Immunoglobulin (Ig) superfamily. SLAMF1 is expressed on hematopoietic cells only and 
constitutes a self-ligand that triggers T cell activation (Cannons et al., 2011; Fouquet et al., 
2018). SLAMF1 is involved in immune responses against various pathogens (van Driel et al., 
2016). Identified as the entry receptor for Measles virus, it controls DC and T cell responses 
along viral infection. In macrophages, SLAMF1 binds S. Typhimurium and E. coli outer 
membrane proteins OmpC and OmpF, thus regulating bacterial phagosome function and 
killing (Berger et al., 2010; Ma et al., 2012). SLAMF1 plays a dual role as both an activator 
and an inhibitor of the immune system during M. tuberculosis and T. cruzi infections 
(Calderon et al., 2012; Pasquinelli et al., 2004). Its role in brucellosis has not yet being 
investigated.  
Here, we demonstrate a specific direct interaction of Brucella Omp25 with the SLAMF1 
receptor in vitro. We show that the Omp25-dependent engagement of SLAMF1 by B. abortus 
functionally limits the pro-inflammatory DC response in vitro as well as splenic DC subset 
expansion and T cell activation during acute infection in vivo, without affecting bacterial 
replication. We further prove that this restriction is essential for bacterial settling during 
chronic infection. Together our results bring to light a yet unrecognised avoidance strategy 
employed by Brucella to prevent recognition and elimination by the immune system thus 
disseminating and establishing its replication niche. Moreover, we show for the first time that 
bacterial replication can be uncoupled from the inflammatory status of the host.  
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Results 
Brucella replication and persistence in bone marrow-derived DCs (BMDCs) are 
independent of Omp25 and SLAMF1 
In a previous transcriptomic study, we were intrigued by the strong up-regulation of SLAMF1 
gene expression in human mo-DCs treated with B. abortus cyclic β1,2-glucan (CβG) (Degos 
et al., 2015) (Table S1). Since SLAMF1 overexpression follows binding of E. coli outer 
membrane proteins OmpC and OmpF to macrophages (Berger et al., 2010; Yurchenko et al., 
2018) and Omp25 modulates human mo-DC activation upon Brucella infection (Billard et al., 
2007), we explored whether B. abortus with or without Omp25 controlled murine SLAMF1 
protein levels in BMDCs in vitro. BMDCs were challenged for 24 h with B. abortus wild-type 
(Ba WT) or a Omp25-defective mutant (Ba ∆omp25) or its complemented mutant strain that 
stably re-expressed Omp25 (Ba ∆omp25pBBR4omp25) or mock-treated or treated with E. 
coli LPS or CβG, as reported (Martirosyan et al., 2012; Zhao et al., 2018) and phenotypic 
investigation was done by flow cytometry (Figure 1a). A marked and similar increase in 
SLAMFI levels, stronger than that obtained in CβG- or E. coli LPS-treated cells, was 
observed with all types of infected samples compared to those of mock-treated BMDCs, 
indicative of a Brucella Omp25-independent control of SLAMF1 upregulation (Figure 1b).  
We then analysed the intracellular replication of the Ba ∆omp25 mutant within BMDCs and 
compared it with that of Ba WT, ∆omp25pBBR4omp25 or ∆virB strains. The Ba ∆omp25 
mutant replicated intracellularly in BMDCs at a rate comparable to that of WT or 
∆omp25pBBR4omp25 strains in contrast to a non-replicative strain, the virB mutant (Figure 
2a), which persisted for 48 h only (Sieira et al., 2000). The ∆omp25 strain replicated within 
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the ER similarly to the WT strain (Figure 2b), showing that both Brucella replication and 
intracellular trafficking in DC are Omp25-independent. When assessing Brucella replication 
in wild type (wt) or Slamf1-/- BMDCs (Figure 2c), equivalent replication rates were obtained 
with all strains or DC genetic backgrounds, indicating that as for Omp25, SLAMF1 
engagement does not affect Brucella replication. 
 
BMDC activation is restrained in an Omp25/SLAMF1-dependent mode upon Brucella 
infection  
We then characterized by flow cytometry the phenotype of BMDCs at 24 h p.i.. In Ba WT-
infected BMDCs, DC activation, reflected by CD80, CD86, CD40 co-stimulatory molecule 
expression levels (Figure 1a), was low compared to that of E. coli LPS-treated control cells 
(Figure 3a), as reported (Conde-Alvarez et al., 2012). However, Ba ∆omp25-infected 
BMDCs exhibited significantly higher expression levels, although still below those of E. coli 
LPS-treated cells. The rescue of the ∆omp25 mutant phenotype by the complemented strain 
(∆omp25pBBR4omp25) demonstrated a direct role of Omp25 in controlling DC surface 
marker expression.  MHCII expression was stable whatever Brucella strain considered and 
below that obtained in LPS-treated cells (Figure S1), supporting the notion that the Ba 
∆Omp25 strain triggers an intermediate level of DC activation. In Slamf1-/- BMDCs, surface 
activation markers were expressed at similar levels regardless of the stimulus (LPS, WT or 
mutant bacteria) (Figures 3a and S1a). Collectively, this revealed a partial Omp25/SLAMF1-
mediated decrease of BMDC activation upon Brucella infection. Likewise, Ba ∆omp25 
infected BMDCs displayed much higher levels of TNF-α, IFN-γ and IL-6 secretion than those 
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in mock or Ba WT-infected wt cells (Figure 3b). In Slamf1-/- BMDCs, cytokine secretion 
elicited by Brucella WT strain was equivalent to that of the ∆omp25 strain (Figure 3b). The 
higher cytokine secretion of the ∆omp25 mutant phenotype in wt BMDCs and loss of 
difference between the Brucella strains in the SLAMF1-deficient BMDCs demonstrated the 
Omp25/SLAMF1-mediated control of DC activation. Hence, the Omp25/SLAMF1 axis finely 
restricts the host inflammatory response triggered by Brucella infection in DCs. 
 
Purified recombinant Brucella Omp25 protein binds SLAMF1 directly 
To determine whether Omp25 is a ligand for the SLAMF1 receptor, we constructed a plasmid 
encoding the N-terminal Myc-tagged extracellular domain of SLAMF1. A similar construct 
with the extracellular domain of another member of the Ig receptor family, CD90, was used as 
a negative control. Immunoprecipitated Myc-containing complexes from protein extracts of 
transfected COS-7 cells were incubated with purified recombinant Brucella Omp25 and 
analysed by Western blot (Figure 4a). SLAMF1 extracellular domain pulled-down Omp25, 
in contrast to that of CD90, which was unable to do so in the presence of 0.1 ng of Omp25, 
although a faint interaction was detected with 1 ng of this recombinant protein. We inferred 
that B. abortus Omp25 protein interacted specifically with ectopically expressed SLAMF1 
extracellular domain since it did not occur with another member of the super Ig family. To 
test if this interaction was shared by other Brucella Omps, the same pull-down approach was 
followed using 0.1 ng of Omp19  (Figure 4b). Purified recombinant B. abortus Omp19 
protein did not interact with either SLAMF1 or CD90 extracellular domains. These findings 
demonstrate the specificity of the interaction of SLAMF1 with Brucella Omp25 protein.  
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The Omp25-dependent engagement of SLAMF1 by Brucella controls NF-κB nuclear 
translocation in BMDCs upon infection  
To assess the impact of the Omp25-dependent engagement  of the SLAMF1 receptor by 
Brucella at early stages of BMDC activation in vitro, we then monitored the translocation of 
NF-κB to the nucleus at 2 h p.i. by confocal immunofluorescence (Figure 5). BMDCs 
infected with Ba ∆omp25 displayed a significantly higher level of nuclear NF-κB than cells 
infected with Ba WT. The rescue of the ∆omp25 mutant phenotype by the complemented 
strain, ∆omp25pBBR4omp25, confirmed the role of Omp25 in limiting nuclear translocation 
of NF-κB in Brucella-infected BMDCs. A significant and comparable increase in nuclear NF-
κB was observed in Slamf1-/- BMDCs following infection with Ba WT or ∆omp25 (Figures 5 
and S2) relative to levels in WT cells. A similar result was obtained in WT BMDCs in the 
presence of a SLAMF1 blocking peptide (Figure S2). The Omp25-dependent engagement of 
SLAMF1 by Brucella in DCs thus limits nuclear translocation of NF-κB, an essential feature 
for pro-inflammatory gene transcription. In accordance with enhanced nuclear NF-κB 
translocation, ∆omp25 infection of BMDCs resulted in an over-expression of Il6, Il12b, Ccl2, 
Il1b, Tnfa, Cxcl1, Nos2 and Ptsg2 at both 6 h and 24 h p.i. compared with cells infected with 
the Ba WT strain (Figure S3). Therefore, the Omp25-SLAMF1 axis restricts the DC 
inflammatory response during Brucella infection.  
    
The Omp25-dependent engagement of SLAMF1 by Brucella limits acute inflammation 
without altering Brucella burden in vivo  
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To investigate the role of the Omp25-dependent engagement of SLAMF1 by Brucella in vivo, 
we carried out infection studies in C57BL/6 mice (Grillo et al., 2012). Spleens were first 
assessed 8 days after intraperitoneal challenge (Figure 6a) during the acute phase of 
infection. A significant increase in spleen weight of ∆omp25-infected wt mice or Slamf1-/- 
mice compared to that of Ba WT-infected C57BL/6J mice suggested an increased 
inflammatory response in the absence of Omp25 or SLAMF1, similar to our findings in vitro. 
Interestingly, equivalent bacterial counts in spleen were enumerated whatever Brucella strain 
or mice considered. No significant difference in granuloma formation, thought to represent 
the host's ability to develop a protective immune response, was detected between the Ba WT-
infected mice and any other infected animals, although there was a trend for an increase in Ba 
∆omp25- versus Ba WT-infected spleens (Figure S4). The Omp25-dependent SLAMF1 
engagement by Brucella seemed to finely tune down the inflammatory response early on in 
vivo during infection without affecting bacterial replication itself. To test such a hypothesis, 
we used a lethal model of mouse brucellosis, the immuno-compromised Ifng-/- mice (Brandao 
et al., 2012). When infected with the Ba WT strain, these mutant mice survived significantly 
longer (until day 30) than those infected with the ∆omp25 strain (all dead by day 25) (Figure 
6b), despite equivalent bacterial CFU counts in the spleen at day 20 p.i. (median of 5.08 ± 0.3 
logCFU/spleen for Ba WT versus 5.27± 0.37 logCFU/spleen for the ∆omp25 mutant). As 
expected, infected animals in a wt background showed no effect on mouse viability. The 
reduced survival of ∆omp25-infected Ifng-/- mice most likely reflects a precocious hyper-
inflammation triggered by the absence of Omp25. Altogether, the Omp25/SLAMF1 axis 
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restrained inflammation at early stages of Brucella infection in vivo without modifying the 
bacterial burden itself.  
 
The Omp25-dependent engagement of SLAMF1 by Brucella prevents splenic expansion 
of all DC subsets, and inhibits downstream T cell activation during the acute phase of 
infection in vivo 
The fact that spleens of wt mice infected by the ∆omp25 mutant were significantly heavier 
than that of mice infected with Ba WT strain and similar to those of Ba WT- or ∆omp25-
infected Slamf1-/- mice, raised the possibility of in vivo Omp25/SLAMF1-dependent changes 
in cellularity of immune cells upon infection. To determine if it was the case, DC splenic 
subsets identified as in Figure 7a, were analysed by flow cytometry at 8 days p.i. (Figure 
7b). Absolute numbers of cDC1, cDC2 and pDC were slightly augmented upon infection with 
Ba WT or ∆omp25pBBR4omp25 strains compared to those detected in Mock PBS-injected 
mice. Loss of Omp25 led to a further rise of these three DC subpopulations to levels akin to 
those seen upon infection with Ba WT or ∆omp25 of Slamf1-/- mice. We next asked whether 
this in vivo modulation of DC splenic subpopulations by the Omp25-dependent engagement 
of SLAMF1 by Brucella affected downstream T cell activation. Percentages and absolute 
numbers of CD4+CD69+ T cells, examined as in Figure 8a, increased with the lack of Omp25 
in Brucella or of SLAMF1 in the host (Figures 8b and S5). The ∆omp25 mutant phenotype 
was again rescued by the complemented strain in wt-infected animals only. Absolute numbers 
of CD8+CD69+ T cells fluctuated similarly (Figures 8b and S5). The Omp25/SLAMF1 axis 
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thus directly controls the expansion of splenic DC subsets and activated T cells in acute 
infection. 
 
The Omp25-dependent engagement of SLAMF1 facilitates persistence of Brucella at the 
chronic phase of infection in vivo  
When finally exploring the impact of the Omp25-dependent engagement of SLAMF1 by 
Brucella in the chronic phase of mouse infection, the situation was different from the acute 
phase (Figure 9). Spleen weights of all infected mice were similar at day 30 p.i.; however, a 
significant reduction in bacterial loads was observed in the spleens of wt mice infected with 
the Ba ∆omp25 mutant or Slamf1-/- mice infected with either Ba strains compared to that in wt 
mice infected with Ba WT. The ∆omp25 mutant phenotype was rescued by the complemented 
strain ∆omp25pBBR4omp25, clearly demonstrating the requirement of Omp25 for optimal 
settling of Brucella at the chronic phase. The comparable phenotype of ∆omp25 mutant in wt 
mice and of the Ba WT and mutant strains in Slamf1-/- mice further supported the assumption 
that Omp25 operates through the engagement of the SLAMF1 receptor.  
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Discussion 
In this study, we identify a role for SLAMF1 in establishment of chronic Brucella infection 
and discover a previously unrecognized interaction partner, B. abortus Omp25, in addition to 
the known Measles virus, S. Typhimurium and E. coli OmpC and OmpF porins. We 
demonstrate that SLAMF1 specifically interacts with B. abortus Omp25 in vitro. Other 
members of the SLAM receptor family sense various microbial components like SLAMF2 
that binds E. coli lectin FimH (van Driel et al., 2016). Future work will determine if other 
features of Brucella are recognized by other SLAM family member(s). Several Brucella 
Omp25 paralogs have been described. The Omp25 family is composed of Omp25/Omp25a, 
Omp25b, Omp25c and Omp25d. Expression of the genes coding for the Omp25 family in 
Brucella spp. have been assessed both at the transcriptomic and protein levels (Martin-Martin 
et al., 2009). Omp25b was not detected in B. abortus and Omp25d was not detected in any 
Brucella spp.. The only paralog beside Omp25/Omp25a that is expressed by B. abortus is 
Omp25c and nothing is known about its role in brucellosis. Further investigation will assess 
whether Omp25c interacts as Omp25 with SLAMF1.  
Brucella Omp proteins have been proposed to be masked by the long-O-chain of LPS, notably 
from complement C1q binding (Eisenschenk et al., 1999). However, several independent sets 
of experiments have demonstrated the exposure and accessibility of Omp25 proteins at the 
surface of Brucella spp.. As such, immunoelectron microscopy using specific anti-Omp25 
antibody detected Omp25 at the surface of B. melitensis B115 cells (Cloeckaert et al., 1996). 
Anti-Omp25 antibodies reversed the inhibition of TNF-α elicited by B. suis infection in a 
human macrophage line (Jubier-Maurin et al., 2001). Given the extremely high homology 
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between Omp25 proteins of Brucella spp., it is more than likely that the same holds true for 
the Omp25 protein of B. abortus. Moreover, the work of Jubier-Maurin et al. supports a direct 
role of Omp25 in the restriction of TNF-α synthesis and secretion seen in our BMDCs during 
B. abortus infection (Figures 3(b) and S3), which also requires SLAMF1, as shown by using 
SLAMF1-deficient cells or SLAMF1 blocking peptide (Figures 3(b) and S2). Variations in 
the apparent molecular sizes of Omp proteins have been attributed to a possible association 
with peptidoglycan of different sizes (Cloeckaert et al., 1992; Sowa et al., 1991). Our in vitro 
pull-down experiments with total protein extracts from Cos7 cells ectopically expressing 
SLAMF1 extracellular domain and put in contact with purified recombinant Omp25 protein 
prove that the interaction of Omp25 with SLAMF1 is direct and does not involve other 
bacterial component. For all these reasons, we consider that upon infection, B. abortus 
Omp25 is not only exposed but has the ability to make direct contact with the SLAMF1 
receptor at the surface of dendritic cells, although this binding, shown in vitro, was not 
formally demonstrated in vivo. A possibility thus remains that alternatively, deletion of 
omp25 deprives Brucella from a component that phenocopies SLAMF1 deficiency in DCs in 
vivo. 
The Omp25-dependent engagement of SLAMF1 by B. abortus in DCs results in a different 
outcome from that triggered by E. coli OmpC and OmpF in macrophages (Berger et al., 2010; 
Ma et al., 2012). We show that neither loss of Omp25 nor SLAMF1 affected Brucella 
intracellular trafficking or bacterial replication. We confirmed our data in vivo, demonstrating 
in mice that Brucella replication is independent of Omp25 and SLAMF1 during acute 
infection. However, when Omp25 or SLAMF1 are missing, the bacterial burden is 
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significantly diminished during chronic infection. By itself the SLAMF1-Omp25 interaction 
does not directly control bacterial replication during early infection but alters the host’s 
response in such way that as a secondary consequence it influences bacterial load at the 
chronic stage. SLAMF1 exhibits versatile functions resulting in either pro- or anti-
inflammatory outcomes (Bleharski et al., 2001; Rethi et al., 2006).  Here, the Omp25-
dependent engagement of SLAMF1 by Brucella in DCs limited nuclear translocation of NF-
κB, subsequently muting pro-inflammatory gene transcription, cytokine/chemokine secretion 
and co-stimulatory molecule expression in vitro. These findings are consistent with prior 
reports showing that Brucella growth in DCs is restrained through secretion of pro-
inflammatory cytokines and that ∆omp25 strains do not trigger bacterial attenuation in human 
mo-DCs or murine macrophages (Billard et al., 2007; Manterola et al., 2007).  In vivo, the 
Omp25-dependent engagement of SLAMF1 by Brucella subtly down-regulated inflammation, 
without affecting bacterial burden during acute infection. This was exemplified by the earlier 
death of Ba ∆omp25-infected mice compared to WT-infected ones in the lethal model of 
brucellosis in spite of invariant bacterial loads. Decreased acute inflammation was illustrated 
in C57BL/6 infected mice by reduced cellularity of immune cells (less splenic DC subsets and 
activated T cells). We infer that the slight decrease of inflammation and activation of DCs and 
T cells at the acute phase of infection elicited by the Omp25-mediated engagement of 
SLAMF1, is not enough to affect bacterial replication per se, as evidenced by stable 
replication in DC in vitro and during acute infection in vivo. However, it may allow Brucella 
to better survive in its replicative niche in DCs, settle in and persist during the chronic phase 
of infection. During the acute phase of infection just after entry in the host, activated immune 
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cells are recruited in lymphoid organs. Later on, during chronic infection, infected cells 
change their metabolism and become anti-inflammatory (Byndloss and Tsolis, 2016b). When 
the Omp25/SLAMF1 axis is missing, immune cells might not switch their metabolism to an 
anti-inflammatory phenotype, and thus continue to produce inflammatory cytokines leading to 
the killing of infected cells. This in turn would result in decreased bacterial loads in Brucella 
abortus Δomp25 strain-infected WT mice or in Slamf1-/-  mice infected with B. abortus WT or 
Δomp25 strains. Our data demonstrate that during acute infection bacterial replication can be 
uncoupled from the inflammatory status of the host and are consistent with the inhibitory 
effect of other Brucella effectors, BtpA and BtpB on the phenotypic maturation and function 
of DCs upon infection (Salcedo et al., 2008; Salcedo et al., 2013). BtpA and BtpB interact via 
their Toll interleukin-1 receptor (TIR) domain with the TLR signalling complex after being 
exported from bacterial membranes and translocated to the host cell cytosol (Salcedo et al., 
2008;: Salcedo et al., 2013 ). However no significant differences were observed in bacterial 
CFU counts between WT Brucella and the btp mutants at different stages of infection (30, 60, 
90, and 130 days) in BALB/c mice (Salcedo et al., 2013), known to exhibit a Th2 phenotype, 
supporting our metabolic switch hypothesis in C57BL/6 mice, which are more Th1. Further 
analyses will determine the validity of such hypothesis.  
Our findings also suggest that the Omp25-dependent engagement of SLAMF1  by Brucella in 
vivo might target critical steps of DC-T cell interactions (Chudnovskiy et al., 2019), as 
SLAMF1 is recognized as a co-stimulatory molecule between DC and T cells (Cocks et al., 
1995). Since without Omp25 Brucella was more potent in inducing expansion of all DC 
subsets and T cell activation, a possible mechanism might be that the Omp25-dependent 
This article is protected by copyright. All rights reserved.
  
engagement of SLAMF1 by B. abortus impedes SLAMF1 homophilic interactions. SLAMF1 
harbours in its cytoplasmic tail immunoreceptor tyrosine-based switch motifs (ITSM), used 
by phosphatases and kinases, recruited through the SLAM adaptor protein (SAP), to control T 
cell activation in a phospho-tyrosine dependent mode (Cannons et al., 2011; Detre et al., 
2010). Recruitment of this cascade may alternatively be impaired. As SLAMF1 is essential 
for TLR4-mediated TRAM-TRIF-dependent signalling in E. coli-infected human 
macrophages (Yurchenko et al., 2018), another possibility is that its engagement by Omp25 
affects the recruitment of other signalling receptor(s) or adapter protein(s). Further 
investigations will decipher how the engagement of the SLAMF1 receptor by Brucella 
Omp25 controls NF-κB nuclear translocation in DCs and define the transduction pathways 
involved and their interplay. 
In conclusion, the Omp25-dependent engagement of SLAMF1 by Brucella illustrates a 
discrete evasion strategy exploited by a Gram-negative bacterium within infected DCs to 
mediate its dissemination in vivo by subtly controlling immune responses in a timely manner 
to foster chronicity. Immune modulation can thus be uncoupled from bacterial replication 
during acute infection. Brucella targeting SLAMF1 may have broader consequences given 
that, on the one hand, Brucella colonizing and persisting in murine bone marrow (Gutierrez-
Jimenez et al., 2018) is transmitted by bone marrow transplantation in humans (Naparstek et 
al., 1982; Tuon et al., 2017), and on the other hand, SLAMF1 is a key cell surface receptor of 
hematopoietic stem cells (Oguro et al., 2013). Investigating the impact of the Omp25-
dependent engagement of SLAMF1 on hematopoietic stem cell maintenance and 
differentiation along Brucella infection should open promising research avenues.  








Animal experimentation was conducted in strict compliance with good animal practice as 
defined by the French animal welfare bodies (Law 87–848 dated 19 October 1987 modified 
by Decree 2001-464 and Decree 2001-131 relative to European Convention, EEC Directive 
86/609). INSERM guidelines have been followed regarding animal experimentation 
(authorization No. 02875 for mouse experimentation). All animal work was approved by the 
Direction Départementale Des Services Vétérinaires des Bouches du Rhône and the Regional 
Ethic Committee (authorization number 13.118). Authorisation of Brucella experimentation 
in BSL3 facility was given under the numbers: AMO-076712016-5, AMO-076712016-6 and 




6-10 week-old female C57BL/6J mice from Charles River, Slamf1-/- mice (kindly provided by 
Yusuke Yanagi) (Davidson et al., 2004) or Ifng-/- (Brandao et al., 2012) mice, both on a 
C57BL/6J background, were used. Animals were housed in cages with water and food ad 
libitum in the CIPHE animal house facility, Marseille. Two weeks before the start of 
experiments, mice were transferred to the BSL3, CIPHE, Marseille, and kept under strict 
biosafety containment conditions all along infection with live bacteria.  Mice were inoculated 
intraperitoneally with 1x10
6
 CFU for each Brucella strain. For survival experiments, mice 
were weighed every two days; when reaching a weight loss of 30%, they were sacrificed.  




B. abortus smooth virulent strain 2308 and the derived strain devoid of Omp25, ∆omp25, 
(corresponding to a deletion of the omp25a  (BAB1_0722) gene, which is regulated by 
BvrR/BvrS (Viadas et al., 2010)) have been described (Manterola et al., 2007).  Details of the 
construction of the complemented version of B. abortus ∆omp25 strain, 
∆omp25pBBR4omp25, are presented below. Brucella strains were grown on Tryptone Soya 
Agar (TSA) plates, supplemented with kanamycin 25 µg/mL for the ∆omp25 strain or 
kanamycin and ampicillin 50 µg/mL for the ∆omp25pBBR4omp25 strain. For infection, 
strains were grown for 16 h approximately at 37°C under shaking in Tryptic Soy Broth 
(TSB), in presence of the appropriate antibiotics when required, until the OD at 600nm 
reached 1.8. All Brucella were kept, grown and used under strict biosafety containment 
conditions all along experiments in the BSL3 facility, Marseille. For sub-cloning of SLAMF1 
and CD90 constructs, Top10 thermo-competent E. coli bacteria were used. Liquid cultures 
were incubated for 16h in Luria Broth (LB) at 37°C under constant shaking and in presence of 
the adequate antibiotics. Solid cultures were grown onto LB agar.  
 
Construction of the complemented B. abortus Δomp25cpBBR4omp25 strain 
The B. abortus omp25a gene was amplified by PCR using HiFi Taq polymerase according to 
manufacturer’s instructions with primers described in Table S2. 7  µl of the PCR product 
were used for A tailing in presence of 1xTaq Buffer, 0.2 mM of ATP, 5 units of Taq during 
30 min at 70°C. 3 µl of this reaction were then ligated into the pGEM-T vector, and ligation 
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product was used to transform E. coli JM109. Clones were purified by miniprep DNA kit 
(Promega) and checked by sequencing. 1 µg of pGEM-T-omp25 plasmid was digested with 
EcoRI HF and BamHI following manufacturer’s instructions along with 1 µg of the pBBR-
MCS4 (ampicillin-resistant destination vector). After separation by electrophoresis, DNA 
fragments were purified from agarose gel using Qiaquick Gel Extraction kit (Qiagen). 7.5 µl 
of insert (pGEM-T-omp25) and 2.5 µl of pBBR-MCS4 were used for ligation with the T4 
DNA ligase for 16 h at 16°C. 5 µl of the ligation was then transformed in E.coli DH5α. The 
plasmid first purified by miniprep DNA kit (Promega) was then conjugated in E. coli. Briefly, 
50 µl of E. coli S17 λpir containing pBBR-MCS4-omp25 were added to 1ml of a stationary 
culture of B. abortus Δomp25. After 2 washes in TSB, the pellet was resuspended in 100 µl of 
TSB and plated for 4h at 37°C in TSA. Bacteria were then re-isolated in a plate containing 
ampicillin (50 µg/ml), kanamycin (25 µg/ml) and nalidixic acid (5 µg/ml) allowing the 
isolation of the B. abortus Δomp25pBBR4omp25 strain. 
 
Cell Culture 
BMDC were prepared from 6-8 week-old C57BL/6J or Slamf1-/- female femurs and tibias as 
previously described (Papadopoulos et al., 2016). Briefly, bone ends were cut off and bone 
marrow was flushed with RPMI 1640  supplemented with 5% FBS, and 50 µM 2-
mercaptoethanol. Red blood cells were removed by 1 min exposure to 1xRBC lysis buffer 
solution. 3x106 cells were seeded onto 6-well plates in 5 mL medium containing 0.8 % 
supernatant of the J558L GM-CSF producing cell line. Medium was changed at day 2.5 and 
BMDCs were ready to use at day 5. Cells were mock-treated or stimulated with E. coli LPS 
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(100 ng/mL), B. abortus CβG (10 µg/mL) or infected for 16 h or 24h. Cells were collected for 
flow cytometry and supernatant was kept at -80°C for cytokine dosage.  
 
Cell culture infection  
BMDCs were infected at a multiplicity of infection (M.O.I.) of 30:1. Bacteria were 
centrifuged onto cells at 400 g for 10 min at 4 ºC and then incubated for 30 min at 37 ºC with 
5% CO2. Cells were washed twice with medium and incubated for 1 h in medium containing 
100 µg/ml gentamicin to kill extracellular bacteria. Thereafter, antibiotics concentration was 
decreased to 20 µg/ml. To monitor bacterial intracellular survival, infected cells were washed 
3 times in 1xPBS and lysed with 0.1% Triton X-100 in H2O. Serial dilutions were plated in 
triplicates onto TSB agar to enumerate CFUs after 3 days at 37°C.  
 
Construction of Myc-SLAMF1(exon 2-3) and Myc-CD90(exon 2-3): 
cDNA of the mouse Slamf1 gene was obtained from Origene and cDNA of the mouse Thy1 
gene was a kind gift from Claude Grégoire (CIML). The two first coding exons of each of 
these cDNA, which encoded the extracellular domain of SLAMF1 or CD90/Thy-1, were 
amplified by PCR using the primers detailed in Table S2 and cloned into a pCMV-Myc 
vector using the Gateway Technology. Plasmids were transformed into thermo-competent E. 
coli Top10 for amplification and then purified with endotoxin-free MaxiPrep Plasmid Kit. 
Clones were checked by sequencing.  
 
Expression and purification of Myc-SLAMF1 exon2-3 or Myc-CD90 exon 2-3: 
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10 µg of Myc-SLAMF1 or Myc-CD90 expression vectors were transfected into COS-7 cells 
using Fugene 6 (Promega) according to manufacturer’s instructions. 48 h after transfection, 
cells were harvested and lysed into 1xPBS, 1 % Triton X-100 in presence of a protease 
inhibitor cocktail. Expression of the transfected proteins was confirmed by western blot 
against the Myc epitope.  
 
Expression of recombinant Omp25 and Omp19 Brucella proteins  
Recombinant U-Omp19 was produced as previously described (Pasquevich et al., 2009) and 
finally stored in following buffer: 50 mM NaH2PO4, 300 mM NaCl pH 7.4. To produce 
Omp25, the complete sequence of B. abortus omp25 gene (GenBank_X79284.1) (de 
Wergifosse et al., 1995) was synthetized and subcloned into pET22(b)+ (Novagen) in frame 
with 6×His-tag (Genscript). Expression and purification was performed as reported (Goel and 
Bhatnagar, 2012). Recombinant purified Omp25 was finally refolded and stored at -20 ºC in 
refolding buffer (50 mM TrisHCl, 1 M NaCl, 0.2 mM DTT, 0.1 mM EDTA, 0.5 M L-
Arginine-HCl, 10% Glycerol, 0.15 M Urea, 3.6 mM Imidazole).  
 
Immunoprecipitation of Myc-SLAMF1 and Myc-CD90 
50 µl of protein G-Dynabeads (Thermofisher) were coupled to 1 µg of anti-c-Myc antibody 
(9E10) during 1 h at 4°C and then incubated with whole transfected COS-7 cell extracts in 
1xPBS, 0.1 % Triton X-100 and protease inhibitors for 1 h at 4°C. After washes in 1xPBS, 
0.1 % NP-40, 0.1 % FBS and protease inhibitor cocktail, Myc-SLAMF1 and Myc-CD90 
immunoprecipitated complexes were incubated 1 h with 1 ng or 0.1 ng of purified 
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recombinant B. abortus Omp25 or Omp19 at 4°C. Washes in 1xPBS, 0.5 M NaCl, 0.001 % 
SDS were then performed to eliminate non-specific interactions. Samples were heated at 70°C 
in Laemmli buffer and centrifuged for 10 min at 14,000 g. Supernatants were denatured at 
95°C for 5 min, prior to loading on 12% SDS PAGE. Western blot against Omp25 or Omp19 
was then performed using Mouse IgG True Blot HRP (Rockland) as a secondary antibody to 
avoid unspecific Ig binding. 
 
RNA extraction and RT  
Total RNA were extracted from infected BMDC using RNeasy Mini Kit (Qiagen) following 
the manufacturer’s instructions. cDNAs were generated with 300 ng of RNA as a template 




2  µl of cDNA corresponding to 6 ng of starting total RNA were used for qPCR. 
Amplification reactions were performed in duplicates with SYBR Green (Takara) in 7500 
Fast Real-time PCR (Applied Biosystem). Hprt was used as a housekeeping gene to 
normalize expression among samples and determine ΔCt. Data are presented as fold increase 
versus Mock treated cells, put arbitrarily at 1.  
 
Cytokine dosage 
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Cytokine profiles (TNFα, IFNγ, and IL-6) in BMDC culture supernatants were analysed by 
cytometric beads assay (BD Biosciences, Mouse Inflammation kit).  
 
Flow cytometry 
Cells were stained for 20 min at 4°C with the antibodies listed in Table S2, then washed once 
in 2% FBS in 1xPBS and once in 1xPBS. Infected cells were then fixed for 20 min in 3 % 
PFA at 22°C. Events were collected by flow cytometry using a FACS LSRII UV or Fortessa 
(BD Biosciences) and analysis was performed on FACS DIVA and FlowJo softwares. For 
BMDC experiments, at least 100,000 CD11c
+
 (DC marker) cells were analysed for MFI 
measurements. For in vivo experiments, DC subset identification followed the following 
strategy: after exclusion of neutrophils, NK cells, B cells, and T cells from live singlet cells, 
CD11cpos cells were divided into CD11cintCD11b-Bst2+SiglecH+ plasmacytoid DC (pDC) and 
CD11chi cells, further identified as XCR1+SIRPα- conventional DC type (cDC)1 and  XCR1-
SIRPα+CD24- cDC2 cells as described (Mattiuz et al., 2018; Schlitzer et al., 2015). T cells 
were identified from live singlet splenic cells by CD3 positivity. CD4+ and CD8+ T cell 
subsets were then assessed for expression of the activation marker CD69. 
 
Immunofluorescence microscopy 
Cells were fixed in 3.2 % paraformaldehyde, pH 7.4, at 22°C for 20 min. For NF-κB 
localisation studies, cells were then permeabilized for 10 min with 0.1 % saponin in 1xPBS, 
followed by 1 h blocking with 2 % BSA in PBS. Primary antibodies were incubated for 1 h 
followed by 2 washes in 1xPBS, 45 min incubation with secondary antibodies, 2 washes in 
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1xPBS and 1 wash in water before mounting with Prolong Gold (ThermoFisher). For the 
other immunofluorescence labelling, 2% BSA in 1xPBS was used for 1 h to block non-
specific interactions. Then primary antibodies were incubated for 30 min in 1xPBS, 0.1 % 
saponin, 0.1 % horse serum. Coverslips with cells were then washed twice in 1xPBS, 0.1 % 
saponin before 30 min incubation with secondary antibodies and were finally mounted in 
Prolong Gold. Samples were examined on a Leica SP5 laser scanning confocal microscope 
for image acquisition. Images of 1024x1024 pixels were then assembled using Adobe 
Photoshop or ImageJ. In all experiments, an anti-CD11c antibody was used to restrict analysis 
to DC only. Antibodies are listed in Table S2. Quantifications were achieved by counting at 
least 50 DCs from 5 independent experiments, for a total of at least 250 DC analysed.  
 
Mouse infection 
6-8 week-old female C57BL/6J (wild-type), Slamf1-/- or Ifng-/- mice were infected in the 
BSL3 facility by intraperitoneal (IP) injection. 1x106 CFU were injected into 200 µl of sterile 
endotoxin-free PBS for each mouse. Organs were harvested at 8, 20 or 30 days p.i, weighted 
and then dissociated into sterile 0.1 % Triton X-100 diluted in H2O. Serial dilutions in sterile 
1xPBS were used to count CFU. Serial dilutions were plated in triplicates onto TSB agar to 
enumerate CFUs after 3 days at 37°C. For cytometry analyses, spleens were harvested, 
digested for 20 min at 37°C with type II collagenase and DNase I and then treated with 10 
mM EDTA to stop digestion. Cut pieces of spleen crushed with a syringe plunger in a 70-μm 
nylon strainer cell strainer were filtered in 1xPBS, 5 mM EDTA, 2 % FBS. After removal of 
red cells by the Red blood cell lysis buffer (eBioscience) single splenic cell suspensions were 
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proceeded for FACS analysis. For histology studies, organs were harvested and placed into 10 
% formalin for 24 h at 22°C before inclusion in paraffin. Slides were then stained with 
hematoxylin and eosin.  
 
Statistical analysis 
Statistical analyses were done using with the GraphPad Prism software. Brown-Forsythe 
ANOVA test followed by variance analysis with the Welch’s test were performed, except for 
TNF-α dosage, for which the multiple comparison Kruskal Wallis ANOVA test, followed by 
variance analysis with the Dunn’s test were applied. Mantel Cox test was used for survival 
curve. All values are expressed as mean ± standard deviation. Differences between values 
were considered significant at p<0.05. *, p<0.05; **, p<0.01; ***, p<0.001). All experiments 
were performed at least three times in triplicate otherwise indicated.  
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Legends to Figures 
Figure 1: In B. abortus-infected DCs, SLAMF1 overexpression is Omp25-independent. (a) 
Flow cytometry characterisation of DCs in vitro upon B. abortus infection. Representative 
FACS profiles of C57BL/6J BMDCs 24 h after mock-treatment or infection with wild-type B. 
abortus (Ba WT). Live singlet DCs were separated from macrophages (F4/80+) and identified 
with the CD11c and MHCII cell surface markers. Expression levels of SLAMF1 and core DC 
activation markers (modal fluorescence) are shown. (b) SLAMF1 expression levels (MFI, 
Median of Fluorescence Intensity) measured by flow cytometry in DCs from C57BL/6J 
BMDCs 24 h after mock-treatment, stimulation with E. coli LPS or B. abortus CβG, or 
infection with Ba WT or  Ba ∆omp25 or ∆omp25pBBR4omp25 mutant strains. 3-5 points per 
group, n= 3. Mean ± SD from pooled data. Significant differences from Ba WT-infected DCs. 
**, p < 0.01; ***, p<0.001. ns, non-significant. Brown-Forsythe ANOVA with Welch’s 
correction. 
 
Figure 2: In infected DCs, B. abortus replication is independent of both Omp25 and 
SLAMF1. (a) Kinetics of bacterial loads for BMDCs infected with B. abortus wild-type (Ba 
WT), ∆omp25, ∆omp25pBBR4omp25 or ∆virB strains. Mean ± SD is shown, n=4. (b) 
Representative confocal microscopy images of C57BL/6J BMDCs infected with Ba WT or 
∆omp25 strains, fixed at 24 h p.i and stained for calnexin (ER staining, red) and anti-Brucella 
LPS (green). Scale bar 10 µm. 50 cells per group, n= 4. (c) Kinetics of bacterial loads for wt 
or Slamf1-/- BMDCs infected with Ba WT, ∆omp25 or ∆omp25pBBR4omp25 strains. Mean ± 
SD is shown, n=4. Mean ± SD from pooled data. Significant differences from Ba WT-infected 
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DCs. ***, p<0.001. Absence of p value, non-significant. Brown-Forsythe ANOVA with 
Welch’s correction. 
 
Figure 3: B. abortus infection inhibits DC activation in an Omp25-SLAMF1-dependent 
mode. (a) DC co-stimulatory molecule levels of expression (mean of fluorescence intensity, 
MFI) from wt or Slamf1-/- BMDCs mock-treated, stimulated with E. coli LPS or infected with 
Ba WT, ∆omp25 or ∆omp25pBBR4omp25 strains for 24 h. Data are expressed as MFI fold 
change versus MFI levels of one set of mock-treated cells put arbitrarily at 1. n=4. (b) 
Cytokine secretion levels from wt or Slamf1-/- BMDCs mock-treated or infected with Ba WT 
or ∆omp25 for 24 h. n=3. Mean ± SD from pooled data. Significant differences from Ba WT-
infected DCs. *, p< 0.05; **, p < 0.01; ***, p<0.001. Absence of p value or ns, non-
significant. Brown-Forsythe ANOVA with Welch’s correction. 
 
Figure 4:  B. abortus Omp25 specifically  interacts with SLAMF1. Immunoblots of protein 
extracts from COS-7 cells expressing Myc-SLAMF1(exons 2-3) or Myc-CD90(exons 2-3) 
showing protein input and Omp25 binding (a) or Omp19 binding (b) to Myc-tag pull-down.  
 
Figure 5:  The Omp25-dependent engagement of SLAMF1 by Brucella limits NF-κB 
translocation in infected DCs.  Confocal micrographs of wt or Slamf1-/- BMDCs mock-
infected or infected with Ba WT, ∆omp25 or ∆omp25pBBR4omp25 for 2h, immunolabelled 
with TOPRO-3 (nucleus, yellow), anti-p65 (NF-κB, red) and anti-CD11c (DC, cyan). Scale 
bar, 10 µm. Bottom right, quantification of nuclear NF-κB in infected cells (n=4, at least 50 
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cells per group). Mean ± SD from pooled data. Significant differences from wt DCs infected 
with Ba WT. *, p< 0.05; ***, p<0.001. Absence of p value, non-significant. Brown-Forsythe 
ANOVA with Welch’s correction. 
 
Figure 6: The Omp25-dependent engagement of SLAMF1 by Brucella restricts inflammation 
without affecting bacterial replication during acute infection in vivo. (a) Spleen weights and 
bacterial loads for C57BL/6J wt and Slamf1-/- mice 8 days after intraperitoneal injection with 
PBS (Mock), B. abortus (Ba) WT or ∆omp25 or ∆omp25pBBR4omp25 strains. 3-5 mice per 
group, n=8. Significant differences from wt mice infected with Ba WT are shown. *, p< 0.05; 
**,  p< 0.01; ***, p<0.001. Absence of p value or ns, non-significant. Brown-Forsythe 
ANOVA with Welch’s correction. (b) Survival curve of wt () or Ifng-/- () mice infected 
with Ba WT (plain lines) or ∆omp25 (dashed lines) strains. 5 mice per group, n=3. Mean ± 
SD from pooled data. Significant differences from mice infected with Ba WT are shown. *, 
p< 0.05. Absence of p value, non-significant. Mantel Cox test. 
 
Figure 7: The Omp25-dependent engagement of SLAMF1 by Brucella restrains expansion of 
splenic DC subsets during acute infection in vivo. (a) Flow cytometry characterisation of 
splenic DCs in vivo upon  B. abortus infection. Representative FACS profiles of one infected 
sample.  For DC analysis, T cells, B cells, NK cells and neutrophils were first excluded from 
live singlet cells and remaining cells were analysed for CD11c and CD11b expression. 
Amongst the CD11cintCD11b- cells, pDC were identified as Bst2+SiglecH+ cells. The two 
conventional DC subsets were characterized among the CD11chi cells, as cDC1 cells for the 
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XCR1+SIRPα- fraction and as cDC2 cells for the SIRPα+XCR1-CD24- fraction. (b) Absolute 
number fold changes of cDC1, cDC2 and pDC over mock-treated wild-type corresponding 
cells from wt or Slamf1-/- mice 8 days after intraperitoneal injection with PBS (Mock), B. 
abortus (Ba) WT or ∆omp25 or ∆omp25pBBR4omp25 strains. 3-5 mice per group, n=3. Mean 
± SD from pooled data. Significant differences from wt mice infected with Ba WT are shown. 
*, p< 0.05; **, p< 0.01; ***, p< 0.001. Absence of p value, non-significant. Brown-Forsythe 
ANOVA with Welch’s correction. 
 
Figure 8: The Omp25-dependent engagement of SLAMF1 by Brucella inhibits T cell 
activation during acute infection in vivo. (a) Flow cytometry characterisation of splenic T 
cells in vivo upon B. abortus infection. Representative FACS profiles of one infected sample.  
T cells were identified from live singlet splenic cells by CD3 positivity. CD4+ and CD8+ T 
cell subsets were then assessed for expression of the activation marker CD69. (b) Absolute 
number fold changes of CD4+CD69+ and CD8+CD69+ T cells over mock-treated wild-type 
cells from wt or Slamf1-/- mice 8 days intraperitoneal injection with PBS (Mock), B. abortus 
(Ba) WT or ∆omp25 or ∆omp25pBBR4omp25 strains. 5-7 mice per group, n=2. Mean ± SD 
from pooled data. Significant differences from wt mice infected with Ba WT are shown. *, p< 
0.05; **, p< 0.01. Absence of p value, non-significant. Brown-Forsythe ANOVA with Welch’s 
correction. 
 
Figure 9: The Omp25-dependent engagement of SLAMF1 by Brucella promotes bacterial 
persistence during chronic infection in vivo. Spleen weights and bacterial loads for wt and 
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Slamf1-/- mice 30 days after injection with PBS (Mock) or B. abortus (Ba) WT or ∆omp25 or 
∆omp25pBBR4omp25 strains. 3-5 mice per group, n=5. Mean ± SD from pooled data. 
Significant differences from wt mice infected with Ba WT are shown. *, p< 0.05; ***, p< 
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